American Assets Investment Management LLC bought a new stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) during the second quarter, Holdings Channel reports. The institutional investor bought 75,720 shares of the company’s stock, valued at approximately $3,739,000.

A number of other large investors have also made changes to their positions in ACHC. DekaBank Deutsche Girozentrale purchased a new position in Acadia Healthcare during the first quarter valued at approximately $3,240,000. Falcon Point Capital LLC purchased a new position in Acadia Healthcare during the first quarter valued at approximately $16,792,000. Monarch Partners Asset Management LLC purchased a new position in Acadia Healthcare during the first quarter valued at approximately $16,079,000. Jennison Associates LLC boosted its position in Acadia Healthcare by 6.3% in the first quarter. Jennison Associates LLC now owns 885,116 shares of the company’s stock valued at $38,591,000 after buying an additional 52,158 shares during the period. Finally, Emerald Advisers Inc. PA boosted its position in Acadia Healthcare by 2.3% in the first quarter. Emerald Advisers Inc. PA now owns 85,198 shares of the company’s stock valued at $3,715,000 after buying an additional 1,876 shares during the period.

Acadia Healthcare Company, Inc. (ACHC) opened at 52.20 on Wednesday. The firm has a market cap of $4.59 billion, a PE ratio of 573.63 and a beta of 1.15. Acadia Healthcare Company, Inc. has a one year low of $32.54 and a one year high of $54.34. The stock has a 50 day moving average of $50.54 and a 200 day moving average of $44.94.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Thursday, July 27th. The company reported $0.66 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.65 by $0.01. The business had revenue of $715.90 million during the quarter, compared to analyst estimates of $717.38 million. Acadia Healthcare had a net margin of 0.30% and a return on equity of 8.69%. The business’s revenue was down 5.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.73 earnings per share. On average, equities analysts forecast that Acadia Healthcare Company, Inc. will post $2.45 earnings per share for the current year.

TRADEMARK VIOLATION NOTICE: This piece was reported by Watch List News and is the property of of Watch List News. If you are accessing this piece on another site, it was illegally stolen and reposted in violation of U.S. and international copyright law. The legal version of this piece can be read at https://www.watchlistnews.com/75720-shares-in-acadia-healthcare-company-inc-achc-acquired-by-american-assets-investment-management-llc/1495042.html.

ACHC has been the subject of several analyst reports. William Blair initiated coverage on shares of Acadia Healthcare in a report on Tuesday, July 18th. They set an “outperform” rating for the company. Zacks Investment Research upgraded shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a report on Friday, April 28th. Jefferies Group LLC set a $55.00 price target on shares of Acadia Healthcare and gave the stock a “buy” rating in a report on Thursday, June 1st. Leerink Swann cut shares of Acadia Healthcare from an “outperform” rating to a “market perform” rating in a report on Monday, May 15th. Finally, BidaskClub upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, July 1st. Five analysts have rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus target price of $59.21.

In other Acadia Healthcare news, EVP Christopher L. Howard sold 16,762 shares of Acadia Healthcare stock in a transaction on Thursday, August 3rd. The shares were sold at an average price of $52.47, for a total value of $879,502.14. Following the completion of the transaction, the executive vice president now owns 200,999 shares of the company’s stock, valued at $10,546,417.53. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Scott Schwieger sold 2,891 shares of Acadia Healthcare stock in a transaction on Monday, July 31st. The stock was sold at an average price of $52.85, for a total transaction of $152,789.35. Following the completion of the transaction, the insider now directly owns 8,841 shares of the company’s stock, valued at approximately $467,246.85. The disclosure for this sale can be found here. In the last ninety days, insiders sold 2,138,347 shares of company stock valued at $105,486,669. 11.10% of the stock is currently owned by corporate insiders.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHC).

Institutional Ownership by Quarter for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.